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A B S T R A C T
Liquid porcine plasma is an animal origin raw material for the manufacturing process of spray-dried porcine
plasma that is used in pig nutrition worldwide. In previous studies we found that the application of ultraviolet
light C (UV-C) in liquid plasma that was inoculated with a variety of bacteria or viruses of importance in the
swine industry can be considered as redundant safety steps because in general achieve around 4 logs reduction
for most of these pathogens. However, the final validation of the UV-C light as safety feature should be con-
ducted with commercial liquid plasma and using the pig bioassay model. As a first objective, the potential
infectivity of a raw liquid plasma product collected from an abattoir was tested by means of a swine bioassay. We
used Porcine circovirus 2 (PCV-2), a ubiquitous virus that has been systematically detected by PCR in porcine
plasma at abattoirs as selection criteria for commercial liquid plasma lot. As a second aim of the study, the effects
of different doses of UV-C irradiation on the selected raw liquid plasma were assayed in the animal bioassay.
Moreover, other swine infecting agents, including Porcine reproductive and respiratory syndrome virus (PRRSV),
were also determined in the original plasma and monitored in the inoculated animals. Pigs negative for PCV-2
and PRRSV genome and antibodies were allotted to one of five groups (6 to 8 pigs/ group) and injected intra-
peritoneally with 10 mL of their assigned inoculum at 50 d of age. Negative control pigs (group 1) were injected
with PBS. Positive control pigs (group 5) were injected with a PCV-2 inoculum. Groups 2, 3 and 4 were injected
with liquid porcine plasma that had been subjected to 0 (raw plasma), 3000 or 9000 J/L UV-C irradiation,
respectively. Group 2 pigs (0 J/L UV-C) got infection by PRRSV but no PCV-2 infection or seroconversion.
However, one pig from group 2 seroconverted to Rotavirus A (RVA) and Hepatitis E virus (HEV) and three group 2
pigs seroconverted to Porcine parvovirus (PPV). Groups 1, 3 and 4 pigs showed no evidence of infection or
seroconversion associated with the tested viruses or any other pathogens found in the liquid plasma before UV-C
irradiation. Group 5 pigs developed PCV-2 infectivity as expected. UV-C irradiation of liquid plasma at 3000 and
9000 J/L was effective in preventing PRRSV and other pathogens transmission. Moreover, raw liquid plasma was
non-infectious for PCV-2 in naïve pigs.
1. Introduction
Plasma from blood of healthy pigs is the raw material used to pro-
duce spray-dried porcine plasma (SDPP), which is a feed ingredient
with functional proteins and bioactive components that is widely used
in pig diets due to its beneficial effects on post-weaning performance
and survival (Coffey and Cromwell, 2001; Torrallardona, 2010). The
manufacturing process of SDPP involves several biosecurity features
including collection only from healthy animals at commercial abattoirs
under competent authorities inspection, pooled blood which contains
antibodies with neutralizing capacity against a variety of pathogens,
spray-drying at 80 ºC throughout its substance, and extended storage
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time at controlled temperature (Blázquez et al., 2017, 2018). However
as technology develops, additional redundant safety features should be
investigated that follows the recommendations of several international
agencies (EMEA, 1996; WHO, 2004).
Ultraviolet light at 254 nm wavelength (UV-C) disrupts cellular
transcription and replication, leading to death bacteria, viruses and
molds (Keyser et al., 2008) due to the formation of thymine-thymine
dimers and thymine-cytosine dimers in DNA molecules and cytosine-
uracil dimers in RNA molecules (Jagger, 1967). UV-C has been ex-
tensively used for disinfection of water (Hijnen, 2006; Lin et al., 2012),
surfaces (Sizer and Balasubramaniam, 1999) and food products
(Guerrero-Beltran and Barbosa-Cánovas, 2004).
It is important to validate individual inactivation steps that are in-
cluded in commercial production processes for SDPP (WHO, 2004). A
swine bioassay including intraperitoneal injection of a test material into
naïve pigs represents an extremely sensitive method to test infectivity
(Christopher-Hennings et al., 2012). In a swine bioassay, it is important
to monitor the pigs after injection with the test material for viremia
and/or seroconversion, which may indicate the presence of infective
virus in the tested material. This procedure is considered a very sensi-
tive method to test the safety of a specific product such as porcine
plasma (Sampedro et al., 2015) and can determine if genome detected
by PCR analyses is infective.
The objective of the present study was to determine if UV-C irra-
diation of liquid commercially collected porcine plasma by a specifi-
cally designed UV system developed for large volumes of opaque liquids
(SurePure Turbulator) could inactivate infective virus as measured in a
pig bioassay. The primary aim was to evaluate inactivation of Porcine
circovirus 2 (PCV-2) because it is not uncommon for commercially
collected plasma to be qRT-PCR positive for this economically im-
portant virus of concern for the global swine industry. Furthermore, the
presence and possible transmission of other potential contaminating
agents of importance for the swine industry, such as Porcine reproductive
and respiratory syndrome virus (PRRSV) Transmissible gastroenteritis cor-
onavirus (TGEV), Swine Influenza A virus (SIV), Porcine parvovirus (PPV),
Porcine epidemic diarrhea virus (PEDV), Swine rotavirus A (RVA), Bovine
viral diarrhea virus (BVDV), Border disease virus (BDV), Hepatitis E virus
(HEV) and Salmonella enterica were evaluated.
2. Materials and methods
2.1. Plasma selection
The criterion for plasma selection was based on the presence of the
PCV-2 genome. The plasma batch that presented a greater number of
PCV-2 genomic copies and at the same time a lower antibody titer
against PCV-2 was selected. Ten 10-L batches of liquid porcine plasma
collected from a commercial abattoir (each batch of plasma was col-
lected from a plasma pool from 10,000 pigs) were frozen (-20 °C) prior
to pre-screen testing for PCV-2 genome and antibodies. The test batch
for use in the UV-C test was selected based on the highest number of
PCV-2 DNA copies measured by real-time quantitative PCR (qRT-PCR)
using a test kit (LSI VetMAXTM Porcine Circovirus Type 2
Quantification, Thermo Fisher Scientific, Massachusetts, USA) and the
lowest level of PCV-2 antibodies analyzed by ELISA (Ingezim Circo
IgG,11.PCV.K.1/5 ELISA, INGENASA, Madrid, Spain) among the pre-
screened liquid plasma batches.
2.2. Plasma UV-C irradiation
Prior to UV-C irradiation, the selected plasma batch (10 L of batch
#9, Table 1) was thawed and filtered to eliminate potential cryopre-
cipitate.
The UV-C reactor (SP1) was designed and manufactured by Sure
Pure Operation AG (Zug, Switzerland). The system is designed to create
turbulent flow (Reynolds number>2400) insuring the delivery of UV-
C radiation to all particles in an opaque liquid. Flow rate was main-
tained at 4000 L/h with the UV lamp switched off. After 5 min of stable
flow, a positive control (1 L at 0 J/L) sample was collected into an
sterile container. Then, the UV-C lamp was switched on and irradiation
started. One liter of treated plasma was collected into sterile containers
at 3000 and 9000 J/L, as previously described (Blázquez et al., 2017).
From the 1-L samples of plasma irradiated at 0 J/L, 3000 J/L and 9000
J/L UV-C, 10 mL were used for intraperitoneal injection in naïve pigs.
2.3. Animals and housing
At approximately 14 days of age, blood samples of selected pigs
were collected at the farm of origin to verify a negative result for PRRSV
antibodies and genome; in addition, these animals had low PCV-2 an-
tibody ELISA S/P values (of maternal origin) and were negative for
PCV-2 qRT-PCR. A total of 40 male piglets (25±3 days of age; initial
average body weight 5±0.5 Kg) were transported and allocated at the
Institut de Recerca i Tecnologia Agroalimentàries (IRTA) experimental
farm in Alcarràs (Lleida, Spain), in individual rooms and separated from
other animals for about three weeks before the start of the study. At the
experimental farm, piglets were sampled at 35 and 45 days of age, and
the experimental groups were established once piglets were proven
seronegative by ELISA against PCV-2 and PRRSV at 50 days of age.
Three pigs were unthrifty during this period and were excluded from
the study; the remaining 37 pigs were weighed, ear-tagged and ran-
domly distributed in five experimental groups of 6 to 8 pigs per group
after matching weights between groups (7 pigs in negative control
group, 8 pigs in each of the 3 treatment groups and 6 pigs in the positive
control group). Each group of animals was allocated in separate boxes
and also in different rooms, thus no air space was shared between
groups. Each box had 7.5 m2 of surface area for the pigs. Environmental
conditions of rooms were maintained at 20-24°C, and an area with a
heat lamp source at 30-35°C was included inside each box. Illumination
consisted of natural light.
To ensure that no cross contamination between treatment groups or
external contamination occurred, rooms were closed, air entry was
regulated, and strict biosafety protocols for the caretakers were im-
plemented. Caregivers were trained to wear TYVEK (DuPont, Delawe,
USA) overalls, overcoats, head coverings and gloves at the entrance of
each room for daily animal care.
2.4. Experimental design and sampling
Group 1 (n = 7) represented the negative control group and was
injected with 10 mL of phosphate buffered saline (PBS) solution (Saline
Solution Vitulia, ERN Laboratories, Barcelona, Spain). Group 2 (n = 8)
pigs were injected with 10 mL of native non-UV-C irradiated plasma
(raw native liquid plasma). Group 3 (n = 8) animals were injected with
10 mL of plasma UV-C irradiated at 3000 J/L. Group 4 (n = 8) pigs
Table 1
Presence of antibodies and genome (copies/mL) of PCV-2 in different porcine
plasma batches, including the selected one (No. 9).
Sample PCV-2 genome copies/mL S/P Elisa IgG PCV-2
1 1.12E+04 0.947
2 1.65E+04 0.864
3 2.06E+04 0.907
4 2.36E+04 0.898
5 2.06E+04 0.880
6 2.71E+04 0.891
7 1.76E+04 0.960
8 5.08E+03 1.011
9 2.71E+04 0.834
10 2.67E+04 0.863
Cut-off Negative 0.284
Cut-off Positive 0.334
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were injected with 10 mL of plasma UV-C treated at 9000 J/L. Group 5
(n = 6) was used as the positive control group and was injected with 10
mL of PCV-2 at a dose of 100 TCID50/mL. All products/inoculum were
administrated by intra-peritoneal route to all groups. Animal proce-
dures were approved by the committee of ethics and welfare with the
protocol approval number CEA-OH/9561/2.
Piglets were monitored daily for clinical signs of infection during a
50-day study period. Blood samples were collected on days 0, 15, 30
and 50 post-injection and tested for viremia and antibody seroconver-
sion against PRRSV, PCV-2, TGEV, SIV, PPV, RVA, PEDV, BVDV, BDV,
HEV and S. enterica.
At the end of the study, the animals were euthanized by an overdose
of sodium pentothal (Euthasol 400®; Laboratorios ECUPHAR,
Barcelona, Spain). All piglets were necropsied and samples of lung,
tonsil, lymph node, bile and feces were collected for further analysis.
2.5. Laboratory procedures
The selected plasma batch was tested for the presence of PCV-2
genome and antibodies, as indicated previously, and was also analyzed
for the presence of other pathogens by commercial qPCR or qRT-PCR
techniques, including PRRSV (LSI VetMAXTM PRRSV EU/NA Real-
Time PCR Kit. Thermo Fisher Scientific, Massachusetts, USA), TGEV
(EXOone TGEV, EXOPOL, Zaragoza, Spain), SIV (EXOone Influenza A,
EXOPOL, Zaragoza, Spain), PPV (EXOone Parvovirus, EXOPOL,
Zaragoza, Spain), PEDV (EXOone PEDV, EXOPOL, Zaragoza, Spain),
RVA (EXOone Rotavirus A, EXOPOL, Zaragoza, Spain), HEV (Path-HEV
advance from Genesig-Primerdesign, Cambridge, UK), and S. enterica
(EXOone Salmonella enterica, EXOPOL, Zaragoza, Spain). BVDV, and
BDV were analyzed by previously published PCR techniques (Blázquez
et al., 2019).
Besides for PCV-2, the presence of antibodies for the following
agents were also evaluated in the plasma batch: PRRSV (IDEXX PRRS
X3 Ab Test ELISA, IDEXX, Hoofddorp, The Netherlands), TGEV
(Ingezim TGEV, INGENASA, Madrid, Spain), SIV (CIVTEST SUIS INF-
LUENZA, Hipra, Amer, Spain), PPV (Ingezim PPV, INGENASA,
Madrid,Spain), RVA (Ingezim Swine Rotavirus, INGENASA, Madrid,
Spain), PEDV (Ingezim PEDV, INGENASA, Madrid, Spain), HEV (ID
Screen Hepatitis E Indirect Multi-species, IDvet Genetics, Grabels,
France) and S. enterica (IDEXX Swine Salmonella Ab, IDEXX,
Hoofddorp, The Netherlands). Antibodies against BVDV, BDV were
evaluated by sero-neutralization tests, following the OIE protocols
(www.oie.int).
After inoculation, animals were monitored for the development of
viremia and antibodies to pathogens identified in the plasma inoculum
(Table 2). Serum samples taken on 50 dpi were analyzed for the pre-
sence of antibodies against PCV-2, PRRSV, TGEV, SIV, PPV, RVA,
PEDV, HEV and S. enterica with the same commercial kits mentioned
above. If antibodies were found in the serum samples 50 dpi, the pre-
sence of virus was determined in the same serum samples (50 dpi) by
qRT-PCR. Serum samples (50 dpi) were tested for PCV-2 and PRRSV by
qRT-PCR.
Serum collected at 15, 30 and 50 dpi and feces (50 dpi) were tested
for PPV and RVA. Bile (50 dpi) was tested for the presence of HEV RNA.
SIV was analyzed (qRT-PCR) in serum and lung tissue (50 dpi) samples
by qRT-PCR with the technique previously cited.
3. Results
3.1. The selected raw plasma as inoculum was positive for several pathogens
Among the 10 porcine plasma batches tested (Table 1), the one with
highest PCV-2 load and lowest PCV-2 antibody values was selected (No.
9). This batch contained 2.71 x 104 PCV-2 DNA copies/mL (Ct = 30.96)
and a Ct value of 35.35 for PRRSV European strain (no number of RNA
copies were provided by the technique). Also, it had ELISA S/P ratios of
0.83 (low to moderate) for PCV-2 and 2.99 (high) for PRRSV anti-
bodies. Furthermore, the selected plasma used as inoculum had anti-
bodies against SIV, RVA, PPV, HEV and S. enterica and presence of low
amounts of nucleic acid of SIV (Ct = 36.41), RVA (Ct = 37.6), PPV (Ct
= 39.44) and HEV (Ct = 37.8) were detected (Table 2).
3.2. UV-irradiated plasma did not transmit any virus
During the experimental period and at necropsy no clinical signs of
infection were observed in any of the piglets.
The negative control group (group 1) remained free from PRRSV
and PCV-2 and showed absence of seroconversion against those viruses
during the entire study period. In contrast, all piglets from group 5
(positive control group, inoculated with PCV-2) became infected with
Table 2
Presence of antibodies (Ab) and genome (PCR) of different infectious agents tested in the porcine plasma inoculum and in the different animal groups.
Group 1 Group 2 Group 3 Group 4 Group 5
Plasma Inoculum Negative control Non-UV plasma UV 3000J/L plasma UV 9000J/L plasma Positive control PCV-2
Pathogen Ab PCR Ab PCR Ab PCR Ab PCR Ab PCR Ab PCR
PCV-2 + + - - - - - - - - + (6/6) + (6/6)
PRRSV EU + + - - + (8/8) + (8/8) - - - - - -
PRRSV US - - - - - - - - - - - -
TGEV - - - na - na - na - na - na
SIV + + - na - na - na - na - na
PPV + - - - + (3/8) Feces - - - - - - -
RVA + + - - + (1/8) Feces - - - - - - -
PEDV - na - na - na - na - na - na
PRV - na - na - na - na - na - na
HEV + + - - + (1/8) Bile - - - - - - -
SVDV - na - na - na - na - na - na
CSFV - na - na - na - na - na - na
BDV - na - na - na - na - na - na
S. enterica + - - na - na - na - na - na
Plasma inoculum (untreated abattoir collected porcine plasma used for bioassay); Group 1 (negative control group of pigs injected ip with saline); Group 2 (pigs
injected ip with untreated abattoir plasma; 0 J/L); Group 3 (pigs injected ip with 3000 J/L UV-C treated plasma); Group 4 (pigs injected ip with 9000 J/L UV-C
treated plasma); Group 5 (positive control group of pigs inoculated with PCV-2).
Ab (serum antibody); PCR (serum genome); + (positive result); - (negative result); na (not analyzed); (n/n) number of pigs with positive antibodies or genome
respect to the total number of pigs in the treatment; Feces (negative fecal result); Bile (negative bile result).
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PCV-2 within 15 dpi as measured by qRT-PCR. These pigs had already
seroconverted against PCV-2 by the following sampling at 30 dpi.
All piglets in group 2 injected with raw native plasma that was not
subjected to UV-C (0 J/L) were found PRRSV positive by qRT-PCR and
seroconverted by 15 dpi. No evidence of PCV-2 infection by qRT-PCR or
ELISA was detected in group 2 (0 J/L UV-C) piglets. Three piglets of this
group seroconverted against PPV at 50 dpi, without evidence of viral
excretion in feces at 50 dpi. One piglet also seroconverted against RVA
at 50 dpi, having a negative qRT-PCR in feces at 50 dpi and in sera at 15
and 30 dpi. By 50 dpi, one group 2 piglet (0 J/L) seroconverted against
HEV without presence of virus in bile. No seroconversion against SIV
was observed in group 2 (0 J/L) piglets.
Piglets in groups 3 and 4 injected intraperitoneally with UV-C ir-
radiated plasma at 3000 J/L and 9000 J/L, respectively did not become
viremic (PCR or RT-PCR) for PCV-2, PRRSV, SIV, PPV, RVA and HEV
and they did not seroconvert at any time during the 50 dpi period.
4. Discussion
The swine bioassay was used to demonstrate the effectiveness of the
UV-C to reduce the viral load that may be present in liquid commercial
plasma in an in vivo model. Intraperitoneal administration was selected
as an administration route to avoid the possible inactivation or loss of
viral particles due to the hydrochloric acid and digestive enzymes in the
gastrointestinal tract (Kasorndorkbua et al., 2002). By the in-
traperitoneal route, the main route of absorption of an inoculated ma-
terial is through the mesenteric blood vessels, which drain into the
portal vein and pass through the liver (Lukas et al., 1971). In con-
sequence, a certain amount of the injected liquid may pass directly
across the diaphragm through small lacunae and into the thoracic
lymph (Abu-Hijleh et al., 1995) and then to systemic circulation. This
technique has been shown to be a very sensitive model to detect in-
fective pathogens (Gerber et al., 2014; Dee et al., 2015; Sampedro et al.,
2015).
Although the commercially collected liquid porcine plasma was
selected for the presence of PCV-2 genome, it also contained antibodies
and presence of small amounts of nucleic acid of different viruses
(PRRSV, SIV, RVA, PPV and HEV), which was consistent with endemic
pathogens present in commercial swine population in the Catalonia,
Spain region (de Deus et al., 2007; López-Soria et al., 2010).
All the piglets in group 2, injected intraperitoneally with 10 mL of
untreated liquid porcine plasma (0 J/L), seroconverted against PRRSV
and, to a lesser percentage, against PPV, RVA and HEV. In the case of
PPV, 3 piglets seroconverted against the virus but no excretion of PPV
was found in feces at the end of the study or its detection in sera during
the experimental period. Similarly, one piglet seroconverted to RVA
while sera and feces remained PCR negative. Furthermore, one piglet
seroconverted against HEV, while the bile remained PCR negative. This
low seroconversion rate could be a result of the extremely low quan-
tities of virus in commercially collected porcine plasma. However, pigs
in groups 3 and 4 injected with liquid porcine plasma treated with UV-C
(3000 J/L or 9000 J/L, respectively) did not seroconvert or become
PCR positive demonstrating that the viral particles present in com-
mercially collected porcine plasma were inactivated.
Interestingly, the commercially collected porcine plasma con-
tained 104 DNA copies/mL PCV-2. However, piglets injected with
untreated plasma (0 J/L) did not become viremic or seroconvert with
PCV-2 indicating that the PCV-2 virus particles were not infective.
The absence of PCV-2 infection could be either associated to the
presence of neutralizing antibodies in commercial pooled plasma, an
inadequate amount of PCV-2 in the intraperitoneal injection to infect
the animals, or that the virus present in raw plasma was already
inactivated despite a positive PCR result. Neutralizing antibodies
naturally present in pooled plasma were reported to inactivate up to
4 log TCID50 of PCV-2 (Polo et al., 2013). This observation also
confirms that a positive PCR test does not imply that the pathogen is
infective. Conversely, group 2 pigs, who received untreated liquid
plasma, seroconverted against PRRSV, being present in the initial
inoculum at a Ct value of 35.35.
SIV RNA was detected in the raw plasma by qRT-PCR, but with a
high Ct number. Since no piglets seroconverted to the virus and no
presence of SIV was found in the analyzed samples (sera and lung qRT-
PCR), it is very likely that the very low load of SIV present in the in-
oculum was unable to cause seroconversion. The low load of SIV pre-
sent in the inoculum was likely a result of contamination at the abattoir.
Due to the administration route selected, infection of the animals was
not expected because SIV is an exclusively respiratory pathogen.
However, if the amount of virus in the inoculum would have been
greater, a seroconversion to the level of immunization could have
happened.
The current data are consistent with previously published research
in which different enveloped and non-enveloped viruses of interest for
the swine industry (PRV, PRRSV, SIV, PPV, PEDV, Swine vesicular dis-
ease virus (SVDV), Classical swine fever virus (CSFV), Bovine viral diarrhea
virus (BVDV), Senecavirus A (SVA) and PCV-2) inoculated in bovine or
porcine plasma were inactivated after UV-C treatment with the same
Sure-Pure Turbulator used in the present study (Blázquez et al., 2019).
These in vitro assays for virus quantification allowed determining the
inactivation capacity of the UV system for the different viruses tested
and confirmed that this step was able to inactivate more than 4 logs for
most of abovementioned viruses (Blázquez et al., 2019).
The World Health Organization (WHO) (WHO, 2004) guidelines on
viral inactivation and removal procedures intended to assure the viral
safety of human blood plasma products establishes that a robust in-
activation process should be capable of removing or inactivating at
least 4 logs of a wide range of viruses (WHO, 2004). In previous studies,
the UV-C irradiation of liquid plasma was able to inactive 4 logs of
different bacteria and viruses (Polo et al., 2015; Blázquez et al., 2017,
2019) and the present study also demonstrated the lack of transmission
of any virus after being UV irradiated at a minimum of 3000 J/L.
Therefore, UV-C irradiation complies with the WHO definition of a
robust inactivation process. Furthermore, the UV-C mechanism of in-
activation (DNA or RNA damage) is different than the thermal in-
activation provided by the spray-drying step.
Overall results indicate that liquid commercial plasma without any
safety treatment and administered intraperitoneally to naïve suscep-
tible pigs was infective for some viruses for which the initial plasma had
virus genome. However, UV irradiation with the SurePure Turbulator
system at 3000 J/L or more was enough to avoid transmission of any of
the tested viruses to the animals. The irradiation at 3000 J/L was
chosen as the level of irradiation for liquid plasma that is used com-
mercially by a specialized blood plasma producer. The opaqueness of a
liquid can limit the penetration of UV-C irradiation and therefore affect
the efficiency of pathogen inactivation (Matak et al., 2005; Groenewald
et al., 2013). However, if sufficient turbulence is introduced into the
liquid, all material is exposed to the surface of the UV source therefore
overcoming the limited penetration of the UV irradiation (Alberini
et al., 2015). The Sure Pure Turbulator (EP-1255444B1) is designed to
create turbulent flow and has been successfully used to pasteurize
opaque liquids like fruit juices, wine (Keyser et al., 2008; Fredericks
et al., 2011) and milk (Donaghy et al., 2009). In addition, in case of
animal plasma, a UV dose of 3000 J/L has been demonstrated to have
no effect on the functionality of proteins present in SDPP (Polo et al.,
2015; Cottingim et al., 2017).
In summary, the results of this study demonstrated that the swine
bioassay is a sensitive technique able to detect infectivity of raw liquid
plasma, confirming the infectiousness of PRRSV but not PCV-2.
Moreover, the UV-C treatment seems to be a useful step to inactivate
potential pathogen contamination of commercially collected animal
plasma subsequently used to produce spray-dried animal plasma.
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